Contact
searchSearch
HMP Global

Calcification

Features

Interview
Tackling the Calcium Challenge: Managing Recoil, Rupture, and Occlusion
04/22/2026
Kumar Madassery, MD
Dr Madassery explores why calcified lesions continue to complicate treatment.
Dr Madassery explores why calcified lesions continue to complicate treatment.
Dr Madassery explores why...
04/22/2026
Vascular Disease Management
Editorial/Commentary
Hard to Crack: The Persistent Challenge of Peripheral Arterial Calcium
12/22/2025
McCall Walker, MD
McCall Walker, MD, discusses the article by Finn et al, "Dealing With Dense Calcium".
McCall Walker, MD, discusses the article by Finn et al, "Dealing With Dense Calcium".
McCall Walker, MD, discusses the...
12/22/2025
Vascular Disease Management
McCall Walker, MD
Video Commentary
The Persistent Challenge of Peripheral Arterial Calcium
12/22/2025
McCall Walker, MD
In this video, McCall Walker, MD, discusses the article by Finn et al, "Dealing With Dense Calcium".
In this video, McCall Walker, MD, discusses the article by Finn et al, "Dealing With Dense Calcium".
In this video, McCall Walker,...
12/22/2025
Vascular Disease Management
Case Series
Dealing With Dense Calcium
12/15/2025
Matthew T. Finn, MD, MS; Sahil A. Parikh, MD, FACC, FSCAI; Pradeep K. Nair, MD, FACC, FSCAI; Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In this case series, the authors illustrate feasible adjunctive strategies for balloon and wire uncrossable calcified chronic total occlusions.
In this case series, the authors illustrate feasible adjunctive strategies for balloon and wire uncrossable calcified chronic total occlusions.
In this case series, the authors...
12/15/2025
Vascular Disease Management
Dr Daniel Clair
ISET 2025
First Clinical Use of a Novel Forward-Shifted Peripheral Intravascular Lithotripsy System: Primary Outcomes of the FORWARD IDE and Feasibility Studies
03/17/2025
Daniel G. Clair, MD
In this video, Dr Daniel Clair, discusses the key findings of the FORWARD PAD IDE trial and its feasability studies.
In this video, Dr Daniel Clair, discusses the key findings of the FORWARD PAD IDE trial and its feasability studies.
In this video, Dr Daniel Clair, ...
03/17/2025
Vascular Disease Management
Interview
Shockwave Intravascular Lithotripsy for Calcified Aortoiliac Occlusive Disease
02/19/2025
Daniel G. Clair, MD
At VEITH 2024, Daniel Clair, MD, gave a presentation on Shockwave IVL for calcified aortoiliac occlusive disease and facilitating large bore access with narrowed calcified iliac arteries. VDM spoke with Dr Clair about his presentation.
At VEITH 2024, Daniel Clair, MD, gave a presentation on Shockwave IVL for calcified aortoiliac occlusive disease and facilitating large bore access with narrowed calcified iliac arteries. VDM spoke with Dr Clair about his presentation.
At VEITH 2024, Daniel Clair, MD,...
02/19/2025
Vascular Disease Management
Dr Marianne Brodmann
AMP 2024
Experience of a Laser and Optics-based Peripheral Intravascular Lithotripsy System for the Treatment of Above-the-Knee Calcified Lesions
09/12/2024
Marianne Brodmann, MD
Watch as Dr. Marianne Brodmann discusses her AMP 2024 presentation on IVL for treatinng above-the-knee calcified lesions.
Watch as Dr. Marianne Brodmann discusses her AMP 2024 presentation on IVL for treatinng above-the-knee calcified lesions.
Watch as Dr. Marianne Brodmann...
09/12/2024
Vascular Disease Management
Press Release
CIS and BRG are First in Louisiana to Use New Generation Diamondback 360 Precision™ Orbital Atherectomy System
06/12/2024

CIS Press Release

CIS Press Release
BATON ROUGE, LA – Dr. Garland Green, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in Louisiana to use the new generation Diamondback 360 Precision™ Orbital Atherectomy System (OAS) to treat coronary...
BATON ROUGE, LA – Dr. Garland Green, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in Louisiana to use the new generation Diamondback 360 Precision™ Orbital Atherectomy System (OAS) to treat coronary...
BATON ROUGE, LA – Dr. Garland...
06/12/2024
Vascular Disease Management

Videos

McCall Walker, MD
Video Commentary
The Persistent Challenge of Peripheral Arterial Calcium
12/22/2025
McCall Walker, MD
In this video, McCall Walker, MD, discusses the article by Finn et al, "Dealing With Dense Calcium".
In this video, McCall Walker, MD, discusses the article by Finn et al, "Dealing With Dense Calcium".
In this video, McCall Walker,...
12/22/2025
Vascular Disease Management
Dr Daniel Clair
ISET 2025
First Clinical Use of a Novel Forward-Shifted Peripheral Intravascular Lithotripsy System: Primary Outcomes of the FORWARD IDE and Feasibility Studies
03/17/2025
Daniel G. Clair, MD
In this video, Dr Daniel Clair, discusses the key findings of the FORWARD PAD IDE trial and its feasability studies.
In this video, Dr Daniel Clair, discusses the key findings of the FORWARD PAD IDE trial and its feasability studies.
In this video, Dr Daniel Clair, ...
03/17/2025
Vascular Disease Management
Dr Marianne Brodmann
AMP 2024
Experience of a Laser and Optics-based Peripheral Intravascular Lithotripsy System for the Treatment of Above-the-Knee Calcified Lesions
09/12/2024
Marianne Brodmann, MD
Watch as Dr. Marianne Brodmann discusses her AMP 2024 presentation on IVL for treatinng above-the-knee calcified lesions.
Watch as Dr. Marianne Brodmann discusses her AMP 2024 presentation on IVL for treatinng above-the-knee calcified lesions.
Watch as Dr. Marianne Brodmann...
09/12/2024
Vascular Disease Management
Dr Yates
ISET 2024
A Summary of Existing Data for the Use of 355nm Laser in BTK Arteries
03/18/2024
Timothy E. Yates, MD, RPVI
Watch as Dr. Timothy Yates reviews his ISET 2024 presentation on the current data available for the use of a 355nm laser in below-the-knee arteries.
Watch as Dr. Timothy Yates reviews his ISET 2024 presentation on the current data available for the use of a 355nm laser in below-the-knee arteries.
Watch as Dr. Timothy Yates...
03/18/2024
Vascular Disease Management
Dr Craig Walker
AMP 2023
The Value of Debulking and Vessel Prep Before Drug Delivery
11/09/2023
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Dr. Craig Walker, from the Cardiovascular Institute of the South in Houma, Louisiana, discusses his presentation on using vessel prep before drug-coated balloon delivery.
Dr. Craig Walker, from the Cardiovascular Institute of the South in Houma, Louisiana, discusses his presentation on using vessel prep before drug-coated balloon delivery.
Dr. Craig Walker, from the...
11/09/2023
Vascular Disease Management
Dr Pena
Video
Cracking Bilateral Iliac Disease With Shockwave M5+
01/04/2023
Constantino S. Peña, MD, FAHA, FSCCT, FSIR
Hear from Dr. Constantino Peña on how he is using Shockwave M5+ to safely crack and compress calcium for his patients with bilateral iliac disease.
Hear from Dr. Constantino Peña on how he is using Shockwave M5+ to safely crack and compress calcium for his patients with bilateral iliac disease.
Hear from Dr. Constantino Peña...
01/04/2023
Vascular Disease Management
Dr Mouawad
Video
Cracking SFA Occlusive Disease With Shockwave M5+
01/04/2023
Nicolas Mouawad, MD, MPH, MBA, FSVS, FRCS, FACS
Hear from Dr. Nicolas Mouawad on how he is using Shockwave M5+ to safely crack and compress calcium for his patients with SFA occlusive disease.
Hear from Dr. Nicolas Mouawad on how he is using Shockwave M5+ to safely crack and compress calcium for his patients with SFA occlusive disease.
Hear from Dr. Nicolas Mouawad on...
01/04/2023
Vascular Disease Management
JD Corl, MD
Video
Cracking Below-the-Knee Disease With Shockwave M5+
01/04/2023

J. D. Corl, MD, FACC, FSCAI

The Christ Hospital, Cincinnati, Ohio

J. D. Corl, MD, FACC, FSCAI The Chri...
Hear from Dr. J. D. Corl on how the is using Shockwave M5+ to safely crack and compress calcium for his patients with difficult below-the-knee disease.
Hear from Dr. J. D. Corl on how the is using Shockwave M5+ to safely crack and compress calcium for his patients with difficult below-the-knee disease.
Hear from Dr. J. D. Corl on how...
01/04/2023
Vascular Disease Management
Video
5 Tips to Optimize Your Shockwave IVL Results
10/14/2022
Misty Humphries, MD; Elizabeth Genovese, MD, MS, FACS, RPVI
In this video, Dr. Misty Humphries and Dr. Liz Genovese review the top 5 tips when using peripheral IVL. Learn more about IVL’s mechanism of action along with these tips to maximize its benefit in cracking superficial and deep calcium.
In this video, Dr. Misty Humphries and Dr. Liz Genovese review the top 5 tips when using peripheral IVL. Learn more about IVL’s mechanism of action along with these tips to maximize its benefit in cracking superficial and deep calcium.
In this video, Dr. Misty...
10/14/2022
Vascular Disease Management
Video
Changing Compliance to Change the Game: IVL for Transfemoral EVAR/TEVAR Access
08/15/2022
Frank Arko, III, MD
In this interview, Frank Arko, MD, Chief of Vascular and Endovascular Surgery at Sanger Heart and Vascular Institute, Atrium Health discusses his use of IVL.
In this interview, Frank Arko, MD, Chief of Vascular and Endovascular Surgery at Sanger Heart and Vascular Institute, Atrium Health discusses his use of IVL.
In this interview, Frank Arko,...
08/15/2022
Vascular Disease Management
Ghassan Abou-Alfa headshot
ASCO 2026
Immunotherapy Plus TACE Emerges as a New Option for Intermediate-Stage Hepatocellular Carcinoma
07/13/2026
Ghassan Abou-Alfa, MD, MBA
Ghassan Abou-Alfa, MD, discusses phase 3 EMERALD-3 results showing that adding STRIDE (tremelimumab plus durvalumab) to transarterial chemoembolization significantly improved progression-free survival in patients with unresectable...
Ghassan Abou-Alfa, MD, discusses phase 3 EMERALD-3 results showing that adding STRIDE (tremelimumab plus durvalumab) to transarterial chemoembolization significantly improved progression-free survival in patients with unresectable...
Ghassan Abou-Alfa, MD, discusses...
07/13/2026
Vascular Disease Management
Michael Pishvaian headshot
Interview
Intra-Arterial Gemcitabine for Patients With Locally Advanced Pancreatic Cancer
06/15/2026
Michael Pishvaian, MD, PhD
Michael Pishvaian, MD, PhD, discusses the phase 3 TIGeR-PaC study evaluating intra-arterial gemcitabine among patients with locally advanced pancreatic cancer.
Michael Pishvaian, MD, PhD, discusses the phase 3 TIGeR-PaC study evaluating intra-arterial gemcitabine among patients with locally advanced pancreatic cancer.
Michael Pishvaian, MD, PhD,...
06/15/2026
Vascular Disease Management
Dr Kak Khee Yeung speaks at ISET 2026.
ISET 2026
Can AI Be of Value in Predicting Type B Dissection Progression Over Time?
04/16/2026
Kak Khee Yeung, MD, PhD
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD,...
04/16/2026
Vascular Disease Management
Dr Mouawad speaks at ISET 2026
ISET 2026
Advancing Thrombectomy and Autologous Blood Reinfusion for Pulmonary Embolism Treatment: Results from the AVENTUS Pivotal Study
04/09/2026
Nicolas J. Mouawad, MD, MPH, MBA
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results...
04/09/2026
Vascular Disease Management
Dr S Jay Mathews speaks at ISET 2026
ISET 2026
Retrievable Scaffold Therapy: Results From Trials
04/07/2026
S. Jay Mathews, MD, MS, FACC, FSCAI
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest...
04/07/2026
Vascular Disease Management
Dr Mary Costantino speaks at ISET 2026.
ISET 2026
Uterine Fibroid Embolization in the OBL: Patient Selection and Workflow Optimization
04/02/2026
Mary Costantino, MD, FSIR
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical...
04/02/2026
Vascular Disease Management
Dr Salazar speaks at ISET 2026
ISET 2026
Venous Valve Technology: When Will It Be Standard of Care?
04/01/2026
Gloria Salazar, MD, FSIR
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current...
04/01/2026
Vascular Disease Management
Dr Gunnar Tepe speaks at ISET 2026
ISET 2026
The State of DCB Technology in 2026: Where Are We Going?
03/31/2026
Gunnar Tepe, MD
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest...
03/31/2026
Vascular Disease Management
Dr Jacques Busquet speaks at ISET 2026.
ISET 2026
The Mystery of Post-EVAR Endotension
03/26/2026
Jacques Busquet, MD
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned...
03/26/2026
Vascular Disease Management
Dr Sanjay Misra speaks at ISET 2026
ISET 2026
Renal Denervation for Refractory Hypertension: Indications, Data, and Outcomes
03/25/2026
Sanjay Misra, MD, FSIR, FAHA, FACR
Interventional radiologist Sanjay Misra, MD, FSIR, FAHA, FACR, from the Mayo Clinic, highlights key insights from his presentation on renal denervation for hypertension.
Interventional radiologist Sanjay Misra, MD, FSIR, FAHA, FACR, from the Mayo Clinic, highlights key insights from his presentation on renal denervation for hypertension.
Interventional radiologist...
03/25/2026
Vascular Disease Management

Presentations

Dr Wittig
LINC 2024
New RCT Hopes to ‘CRACK-IT’ With Aggressive Vessel Prep in Heavily Calcified Fempop Lesions
05/29/2024

Tim Wittig, MD
University Hospital Leipzig, Germany

Tim Wittig, MD University Hospital Le...
An introduction to a new trial focused on aggressive vessel preparation took center stage on Wednesday as part of a ‘last frontiers’ session tackling severely calcified lesions. Tim Wittig detailed the CRACK-IT trial.
An introduction to a new trial focused on aggressive vessel preparation took center stage on Wednesday as part of a ‘last frontiers’ session tackling severely calcified lesions. Tim Wittig detailed the CRACK-IT trial.
An introduction to a new trial...
05/29/2024
Vascular Disease Management
AMP Live Case
Presentations
Intravascular Lithotripsy for Multi-Level CLI
09/01/2020
In this session, Dr. Chris Metzger performs TWO Shockwave IVL cases – one calcified CFA and one bilateral aortoiliac occlusive disease (AIOD). Drs. Craig Walker, George Adams, Constantino Pena, Ehrin Armstrong and Michael Lichtenberg provide...
In this session, Dr. Chris Metzger performs TWO Shockwave IVL cases – one calcified CFA and one bilateral aortoiliac occlusive disease (AIOD). Drs. Craig Walker, George Adams, Constantino Pena, Ehrin Armstrong and Michael Lichtenberg provide...
In this session, Dr. Chris...
09/01/2020
Vascular Disease Management
Videos
AMP Presents CLI Live Series Case 2
07/14/2020
Complex CLI intervention performed at Advanced Cardiac and Vascular Centers for Amputation Prevention, an outpatient CLI center.
Complex CLI intervention performed at Advanced Cardiac and Vascular Centers for Amputation Prevention, an outpatient CLI center.
Complex CLI intervention...
07/14/2020
Vascular Disease Management
Mike Watts, MD, FSIR
AMP 2026
When Economics Meets Innovation: Matching Deep Venous Arterialization to the Right Site of Service
08/07/2026
Mike Watts, MD, FSIR
08/07/2026
Vascular Disease Management
Dr Yana Etkin
AMP 2026
Early Detection and Timely Reintervention Drive Success After Deep Venous Arterialization
08/07/2026
Yana Etkin, MD, FSVS, FACS
Yana Etkin, MD,  presented an in-depth review of strategies for identifying and managing failing DVA, emphasizing that long-term success depends not only on creating the DVA circuit but also on maintaining its patency through vigilant...
Yana Etkin, MD,  presented an in-depth review of strategies for identifying and managing failing DVA, emphasizing that long-term success depends not only on creating the DVA circuit but also on maintaining its patency through vigilant...
Yana Etkin, MD,  presented an...
08/07/2026
Vascular Disease Management
Alik Farber, MD
AMP 2026
Four-Year BEST-CLI Data Reinforce a Team-Based Future for Limb Salvage
08/07/2026
Alik Farber, MD
Alik Farber, MD, MBA, presented the latest 4-year findings from the landmark BEST-CLI trial. He challenged attendees to move beyond the long-standing debate of surgery vs endovascular intervention and instead embrace an evidence-based,...
Alik Farber, MD, MBA, presented the latest 4-year findings from the landmark BEST-CLI trial. He challenged attendees to move beyond the long-standing debate of surgery vs endovascular intervention and instead embrace an evidence-based,...
Alik Farber, MD, MBA, presented...
08/07/2026
Vascular Disease Management
Dr Eric Secemsky
AMP 2026
Defining Optimal Medical Therapy for CLTI in 2026
08/07/2026
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
Dr Eric Secemsky presented a review of the evidence supporting contemporary medical management for patients with PAD and CLTI, emphasizing that pharmacologic therapy remains an essential pillar of reducing cardiovascular events.
Dr Eric Secemsky presented a review of the evidence supporting contemporary medical management for patients with PAD and CLTI, emphasizing that pharmacologic therapy remains an essential pillar of reducing cardiovascular events.
Dr Eric Secemsky presented a...
08/07/2026
Vascular Disease Management
Dr Ralf Langhoff
AMP 2026
Retrograde Access Moves to the Forefront: Rethinking CTO Crossing Strategies
08/06/2026
Ralf Langhoff, MD
During a Thursday afternoon session at the Amputation Prevention Symposium 2026, Ralf Langhoff, MD, asked attendees to reconsider when retrograde access should be used for chronic total occlusion (CTO) interventions.
During a Thursday afternoon session at the Amputation Prevention Symposium 2026, Ralf Langhoff, MD, asked attendees to reconsider when retrograde access should be used for chronic total occlusion (CTO) interventions.
During a Thursday afternoon...
08/06/2026
Vascular Disease Management
Dr Ramon Varcoe
AMP 2026
Bioresorbable Below-the-Knee Technology Shows Durable Promise for CLTI
08/06/2026
Ramon L. Varcoe, MBBS, MS, PhD
Dr Ramon L. Varcoe presented an update on bioresorbable BTK technology, highlighting the growing body of evidence supporting the Esprit™ BTK drug-eluting resorbable scaffold (Abbott Cardiovascular) for the treatment of CLTI.
Dr Ramon L. Varcoe presented an update on bioresorbable BTK technology, highlighting the growing body of evidence supporting the Esprit™ BTK drug-eluting resorbable scaffold (Abbott Cardiovascular) for the treatment of CLTI.
Dr Ramon L. Varcoe presented an...
08/06/2026
Vascular Disease Management
Dr Pradeep Nair
AMP 2026
A New Approach to Crossing and Preparing Complex Peripheral Chronic Total Occlusions
08/06/2026
Pradeep K. Nair, MD, FACC, FSCAI
Dr Pradeep K. Nair presented the clinical rationale, engineering design, pivotal clinical data, and early real-world experience with the Santreva-ATK Endovascular Revascularization Catheter (AngioSafe).
Dr Pradeep K. Nair presented the clinical rationale, engineering design, pivotal clinical data, and early real-world experience with the Santreva-ATK Endovascular Revascularization Catheter (AngioSafe).
Dr Pradeep K. Nair presented the...
08/06/2026
Vascular Disease Management
S Jay Mathews, MD
AMP 2026
SELUTION SLR Highlights the Growing Role of Sirolimus Drug-Eluting Balloons in CLTI
08/06/2026
S. Jay Mathews, MD, MS, FACC, FSCAI
This presentation examined the evolving evidence supporting the SELUTION SLR sirolimus drug-eluting balloon (Cordis) as a treatment strategy for femoropopliteal and BTK PAD, with particular emphasis on complex CLTI.
This presentation examined the evolving evidence supporting the SELUTION SLR sirolimus drug-eluting balloon (Cordis) as a treatment strategy for femoropopliteal and BTK PAD, with particular emphasis on complex CLTI.
This presentation examined the...
08/06/2026
Vascular Disease Management
Tim Wittig, MD
AMP 2026
MOTIV BTK Trial Demonstrates Promising Early Outcomes for Sirolimus-Eluting Bioresorbable Scaffold in CLTI
08/05/2026
Tim Wittig, MD
Tim Wittig, MD, presents the primary outcomes from the MOTIV BTK Trial, which evaluated the safety and efficacy of the sirolimus-eluting bioresorbable scaffold MOTIV BTK.
Tim Wittig, MD, presents the primary outcomes from the MOTIV BTK Trial, which evaluated the safety and efficacy of the sirolimus-eluting bioresorbable scaffold MOTIV BTK.
Tim Wittig, MD, presents the...
08/05/2026
Vascular Disease Management
Dr Eric Scott
AMP 2026
Using Imaging to Choose Between Endovascular Therapy and Surgical Bypass
08/05/2026
Eric C. Scott, MD
Dr Eric Scott presents presents a case-based discussion on how advanced vascular imaging should guide the decision between an endovascular-first or surgical bypass-first approach for patients with PAD and CLTI.
Dr Eric Scott presents presents a case-based discussion on how advanced vascular imaging should guide the decision between an endovascular-first or surgical bypass-first approach for patients with PAD and CLTI.
Dr Eric Scott presents presents...
08/05/2026
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Press Release
CIS and BRG are First in Louisiana to Use New Generation Diamondback 360 Precision™ Orbital Atherectomy System
06/12/2024

CIS Press Release

CIS Press Release
BATON ROUGE, LA – Dr. Garland Green, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in Louisiana to use the new generation Diamondback 360 Precision™ Orbital Atherectomy System (OAS) to treat coronary...
BATON ROUGE, LA – Dr. Garland Green, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in Louisiana to use the new generation Diamondback 360 Precision™ Orbital Atherectomy System (OAS) to treat coronary...
BATON ROUGE, LA – Dr. Garland...
06/12/2024
Vascular Disease Management
News
Shockwave Medical Announces U.S. Launch of New Peripheral IVL Catheter
03/14/2023
Shockwave L6 Provides Physicians with Larger-Diameter Catheters to Expand Potential Treatment of Peripheral Vessels
Shockwave L6 Provides Physicians with Larger-Diameter Catheters to Expand Potential Treatment of Peripheral Vessels
Shockwave L6 Provides Physicians...
03/14/2023
Vascular Disease Management
Press Release
SCAI Scientific Sessions: Shockwave IVL Maintains Superiority to Angioplasty in Calcified Peripheral Disease at Two Years
05/19/2022
Randomized Disrupt PAD III Study Finds Superior Vessel Preparation Leads to Excellent Long-Term Outcomes and Preserved Future Treatment Options
Randomized Disrupt PAD III Study Finds Superior Vessel Preparation Leads to Excellent Long-Term Outcomes and Preserved Future Treatment Options
Randomized Disrupt PAD III Study...
05/19/2022
Vascular Disease Management
Press Release
Fluidx Completes Submission of Premarket Approval Application for the GPX® Embolic Device
07/24/2026
Salt Lake City (UT) – 07/24/2026 Fluidx Medical Technology, Inc., a clinical stage medical device company advancing its portfolio of embolic technologies, announced that it recently submitted to the U.S. Food and Drug Administration (FDA) the...
Salt Lake City (UT) – 07/24/2026 Fluidx Medical Technology, Inc., a clinical stage medical device company advancing its portfolio of embolic technologies, announced that it recently submitted to the U.S. Food and Drug Administration (FDA) the...
Salt Lake City (UT) – 07/24/2026...
07/24/2026
Vascular Disease Management
Thrombectomy
THUNDER Study Demonstrates Penumbra’s THUNDERBOLT is Safe and Effective for Stroke Care
07/22/2026
ALAMEDA, Calif. – Penumbra, Inc. announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLT™, the company’s novel...
ALAMEDA, Calif. – Penumbra, Inc. announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLT™, the company’s novel...
ALAMEDA, Calif....
07/22/2026
Cath Lab Digest
Stroke Interventions
Imperative Care Launches Ikon 24 Pro Guidewire, Enhancing the Zoom Stroke System to Support More Efficient Stroke Procedures
07/17/2026
CAMPBELL, Calif., July 16, 2026 — Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced the launch of the Ikon™ 24 Pro Guidewire, a next-generation...
CAMPBELL, Calif., July 16, 2026 — Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced the launch of the Ikon™ 24 Pro Guidewire, a next-generation...
CAMPBELL, Calif., July 16, 2026...
07/17/2026
Vascular Disease Management
Liver Tumor Ablation
First Meta-analysis Supports Histotripsy for Liver Tumor Ablation
07/14/2026
Laura Simson, MA
Histotripsy demonstrated high technical success and an encouraging safety profile for the treatment of primary and secondary liver tumors in the first systematic review and meta-analysis to report the technology's clinical evidence.
Histotripsy demonstrated high technical success and an encouraging safety profile for the treatment of primary and secondary liver tumors in the first systematic review and meta-analysis to report the technology's clinical evidence.
Histotripsy demonstrated high...
07/14/2026
Vascular Disease Management
Radiation Safety
Landmark Multi-Society Consensus Signals New Era in Occupational Radiation Safety; Rampart Positioned to Accelerate Adoption of Lead-Free Enhanced Radiation Protection
07/14/2026
BIRMINGHAM, Ala. — July 14, 2026 — Rampart, the global leader in enhanced radiation protection devices (ERPD), today welcomed the publication of a landmark multi-society expert consensus statement that calls for a fundamental shift in...
BIRMINGHAM, Ala. — July 14, 2026 — Rampart, the global leader in enhanced radiation protection devices (ERPD), today welcomed the publication of a landmark multi-society expert consensus statement that calls for a fundamental shift in...
BIRMINGHAM, Ala. — July 14, 2026...
07/14/2026
Vascular Disease Management
GPX Embolic Device
GPX® Embolic Device Meets Primary Endpoints in an Investigational Device Exemption (IDE) Pivotal Trial
07/14/2026
Salt Lake City (UT) – Fluidx Medical Technology, Inc. announced the positive results from the Investigational Device Exemption (IDE) pivotal clinical trial evaluating the GPX Embolic Device. In the 114 patients that were treated in the trial,...
Salt Lake City (UT) – Fluidx Medical Technology, Inc. announced the positive results from the Investigational Device Exemption (IDE) pivotal clinical trial evaluating the GPX Embolic Device. In the 114 patients that were treated in the trial,...
Salt Lake City (UT) – Fluidx...
07/14/2026
Vascular Disease Management
Transarterial Chemoembolization
STRIDE-Based Regimens Plus TACE Improve Outcomes vs TACE Alone in Embolization-Eligible Hepatocellular Carcinoma
07/13/2026
Stephanie Holland
Results from the phase 3 EMERALD-3 trial demonstrated that combining STRIDE-based immunotherapy with TACE, with or without lenvatinib, significantly improved progression-free survival compared with TACE alone, supporting a potential new...
Results from the phase 3 EMERALD-3 trial demonstrated that combining STRIDE-based immunotherapy with TACE, with or without lenvatinib, significantly improved progression-free survival compared with TACE alone, supporting a potential new...
Results from the phase 3...
07/13/2026
Vascular Disease Management
Peripheral Intervention
3-Year DETOUR2 Results Demonstrate Sustained Symptom Relief and Limb Preservation in Complex SFA Disease
07/09/2026
Data from one of the first studies in long-segment (>30 cm) FP disease show durable patency, low reintervention rate, and high limb salvage through 36 months.
Data from one of the first studies in long-segment (>30 cm) FP disease show durable patency, low reintervention rate, and high limb salvage through 36 months.
Data from one of the first...
07/09/2026
Cath Lab Digest
Thrombectomy for Stroke
First Patient Enrolled in Penumbra’s FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke
07/07/2026
ALAMEDA, Calif. - Penumbra, Inc. announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer...
ALAMEDA, Calif. - Penumbra, Inc. announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer...
ALAMEDA, Calif. - Penumbra, Inc....
07/07/2026
Cath Lab Digest
Embolization
Fluidx Announces Continued Clinical Success with ULTRA Embolic Gel
07/02/2026
SALT LAKE CITY, UT — July 02, 2026 — Fluidx Medical Technology, Inc. today announced that its ULTRA Embolic Device continues to see clinical success and was most recently used to treat a large, right-sided renal cell carcinoma (RCC) tumor at...
SALT LAKE CITY, UT — July 02, 2026 — Fluidx Medical Technology, Inc. today announced that its ULTRA Embolic Device continues to see clinical success and was most recently used to treat a large, right-sided renal cell carcinoma (RCC) tumor at...
SALT LAKE CITY, UT — July 02,...
07/02/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use